THANK YOU FOR SUBSCRIBING


Zhishen Yang, General ManagerIn July 2021, ICH released the highly anticipated Q13 guidance on continuous manufacturing of APIs, which provides in-depth and comprehensive guidance in many aspects, including coverage and discussion of technical issues. ICH Q13 consists of a main guideline and five appendices. The guideline clarifies the concept of continuous manufacturing, describes scientific methods, and proposes regulatory considerations for the continuous manufacturing of APIs.The guideline applies the batch definition of ICH Q7 to continuous manufacturing. A batch can be defined according to the quantity of output materials, the quantity of input materials, or the running time under a determined mass flow. At the same time, a batch can be defined as a range.
Flow chemistry using microchannel technology has many advantages, such as: super heat and mass transfer ability, horizontal flow reaction, small liquid holdup, intrinsic safety, easy scale-up, high pressure resistance and corrosion resistance, and can be connected to online IR, online Raman spectrum, online nuclear magnetic and other equipment to monitor the reaction.
In the process of large-scale production of global pharmaceutical enterprises, they will use some cutting-edge technologies: flow chemistry technology, enzyme catalysis technology, metal catalysis technology, and AI technology. For the design process, if these technologies can be combined, it will have a great impact on the promotion of the launch of products and the reduction of costs.
Using flow chemistry to optimize the reaction can improve the process efficiency. The precise control of reaction parameters, such as time, temperature, molar ratio of reagents, etc., can be easily screened by using automated methods, so that chemists can leave and continue to engage in other work. Compared with the usual traditional time-consuming method, the flow chemistry method can meet many conditions that chemists want to see by using only one reactor.
Since flow chemistry can provide chemists with benefits - such as better reaction control, greater selectivity, and increased chemical space - it is an excellent way to rapidly synthesize a large library of compounds, and has been adopted by all top pharmaceutical companies in some form by companies around the world. The drug compound library can be rapidly synthesized and screened using an automatic sampler, thus avoiding manual loading of reagents between two experiments, and a flow chemical reactor can automatically run more than 100 experiments in the shortest set time. In addition, once found successful, it is very easy to re synthesize the compound for further research. Flow chemistry technology is also very useful for the generation of compound libraries, screening reactions and optimization studies, because it is easy to handle a small number of compounds, which is important when using expensive materials such as enzymes.
Shanghai XFlow Chemical Technology Co., Ltd. is a company specializing in flow chemical process development and new catalyst application research. The company is located in building 5, No. 3399, Kangxin Road, Shanghai. It has a 1600 square meter R & D laboratory in Shanghai with 35 employees.
There are various reactors in the laboratory, such as CSTR, PFR, micro-channel reactor, continuous air oxidation reactor, continuous Grignard reactor, fixed bed, trickle bed reactor, tube in tube gas-liquid reactor, continuous photo reactor and other flow chemical reactor devices. A 5000 square meter pilot plant in Jiangxi Province is also under construction.
XFlowChem has process development / reactor design / process simulation / engineering design / process safety / analysis support and other departments.![]()
Flow chemistry technology is very useful for generating compound libraries, screening reactions and optimization studies. In addition, handling a small number of compounds is easy, which is important when using expensive materials
XFlowChem has the following flow process development capabilities:
Study on thermodynamics and kinetics of chemical reactions;
Process simulation based on reaction kinetics data (Using Dynochem software);
Design of continuous reactor;
Combined application of multiple continuous reactors;
Flow process design of work-up procedure(quenching, extraction, water washing, concentration)
Engineering design (Using Aspen or ChemCAD)
XFlowChem has some experience in the continuous process development of the following reactions:
Nitration reaction (concentrated sulfuric acid system, dichloroethane system);
Oxidation reaction (Tempo; Swern; H2O2; ozone; air; nitric acid)
Metal reagent reaction (butyl lithium, Grignard reagent, DIBAL-H, etc.)
Diazotization and subsequent reaction of diazonium salt;
Hydrogenation reaction;
Photochemistry reaction;
Coupling reaction;
Azide reaction;
Esterification reaction;
Amination / reductive amination reaction;
Strong exothermic reaction;
Dangerous reagent;
XFlowChem has implemented multi-step continuous processes for many products, helped customers realize the upgrading and transformation of the traditional batch reactor process to continuous flow technology, and helped customers develop new catalyst processes, achieving very good social and economic effects.
Company
Shanghai XFlow Chemical Technology Co., Ltd.
Management
Zhishen Yang, General Manager
Description
As the process of bringing new drugs to market is extremely challenging, with an average cost of $2.6billion and a maximum of 12 years, it is crucial for pharmaceutical companies to optimize the drug discovery and development process to maximize the drug life cycle before the patent expires.